| Toxicology |
1 |
1 |
| Arrhythmia |
0 |
0.97 |
| Clinical Guidelines |
0 |
0.99 |
| Treatment Guidelines |
0 |
0.46 |
| Cardiac Arrest |
0 |
0.98 |
| Opioids |
0 |
0.32 |
| Overdose |
0 |
0.3 |
| Acute Pain |
0 |
0.29 |
| Addiction |
0 |
0.29 |
| Calcium Channel Blockers |
0 |
0.27 |
| Pain Management |
0 |
0.26 |
| Refractory |
0 |
0.26 |
| Resuscitation |
0 |
0.26 |
| Beta-Adrenergic Agonist |
0 |
0.19 |
| Calcium |
0 |
0.19 |
| Extracorporeal Membrane Oxygenation (ECMO) |
0 |
0.19 |
| Lipids Management |
0 |
0.19 |
| Local Anesthetic Toxicity |
0 |
0.19 |
| Cardiogenic Shock |
0 |
0.18 |
| Local Anesthetic |
0 |
0.18 |
| Depression |
0 |
0.17 |
| Osteoarthritis |
0 |
0.16 |
| Anesthesia |
0 |
0.13 |
| Child |
0 |
0.13 |
| Heart |
0 |
0.13 |
| Shock |
0 |
0.13 |
| Healthcare and Medical Technology |
0 |
0.09 |
| Acidosis |
0 |
0.06 |
| Agitation |
0 |
0.06 |
| Benzodiazepines |
0 |
0.06 |
| Central Nervous System |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Drug Interaction |
0 |
0.06 |
| Hospital |
0 |
0.06 |
| Hyperthermia |
0 |
0.06 |
| Injury |
0 |
0.06 |
| Insulin Therapy |
0 |
0.06 |
| Intravenous |
0 |
0.06 |
| Lung |
0 |
0.06 |
| Rhabdomyolysis |
0 |
0.06 |
| Sedative |
0 |
0.06 |
| Stomach |
0 |
0.06 |